Panton-Valentine leukocidin positive MRSA in 2003: the Dutch situation

Area of Science:

• Microbiology
• Infectious Diseases
• Epidemiology

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat.
• The Panton-Valentine leukocidin (PVL) toxin is associated with severe MRSA infections.
• Understanding the epidemiology of PVL-MRSA is crucial for effective control.

Purpose of the Study:

• To analyze the prevalence and genetic characteristics of PVL-MRSA in the Netherlands in 2003.
• To compare Dutch PVL-MRSA genotypes with known global epidemic strains.
• To investigate the emergence patterns of PVL-MRSA in hospital settings.

Main Methods:

• Analysis of MRSA isolates collected in the Netherlands in 2003.
• Detection of Panton-Valentine leukocidin (PVL) gene loci.
• Molecular subtyping using sequence typing (ST) to identify MRSA genotypes.

Main Results:

• 8% of hospital-acquired MRSA isolates carried the PVL gene loci.
• Most Dutch PVL-MRSA genotypes aligned with established global epidemic types.
• Sequence types ST8, ST22, ST30, ST59, and ST80 were the most common PVL-MRSA genotypes.
• A notable increase in ST8 MRSA was observed, rising from 1% in 2002 to 17% in 2003.

Conclusions:

• PVL-MRSA strains circulating in the Netherlands in 2003 were largely consistent with global epidemic types.
• The emergence of PVL-MRSA is not limited to the community and can occur within hospital environments.
• Continued surveillance of PVL-MRSA is essential to monitor evolving resistance and virulence patterns.